Literature DB >> 21082268

Practice based evidence of the beneficial impact of PET in patients with brain tumors.

Homer A Macapinlac, Johannes Czernin, Steven M Larson.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21082268     DOI： 10.1007/s11307-010-0446-2

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


× No keyword cloud information.
  4 in total

1.  Prediction of survival in glioma patients by means of positron emission tomography.

Authors:  N J Patronas; G Di Chiro; C Kufta; D Bairamian; P L Kornblith; R Simon; S M Larson
Journal:  J Neurosurg       Date:  1985-06       Impact factor: 5.115

2.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

Authors:  G Di Chiro; R L DeLaPaz; R A Brooks; L Sokoloff; P L Kornblith; B H Smith; N J Patronas; C V Kufta; R M Kessler; G S Johnston; R G Manning; A P Wolf
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

3.  Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

Authors:  N J Patronas; G Di Chiro; R A Brooks; R L DeLaPaz; P L Kornblith; B H Smith; H V Rizzoli; R M Kessler; R G Manning; M Channing; A P Wolf; C M O'Connor
Journal:  Radiology       Date:  1982-09       Impact factor: 11.105

4.  Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.

Authors:  Bruce E Hillner; Barry A Siegel; Dawei Liu; Anthony F Shields; Ilana F Gareen; Lucy Hanna; Sharon Hartson Stine; R Edward Coleman
Journal:  J Clin Oncol       Date:  2008-03-24       Impact factor: 44.544
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.